AbouAitah, K.; Allayh, A.K.; Wojnarowicz, J.; Shaker, Y.M.; Swiderska-Sroda, A.; Lojkowski, W.
Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses. Pharmaceutics 2021, 13, 2174.
https://doi.org/10.3390/pharmaceutics13122174
AMA Style
AbouAitah K, Allayh AK, Wojnarowicz J, Shaker YM, Swiderska-Sroda A, Lojkowski W.
Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses. Pharmaceutics. 2021; 13(12):2174.
https://doi.org/10.3390/pharmaceutics13122174
Chicago/Turabian Style
AbouAitah, Khaled, Abdou K. Allayh, Jacek Wojnarowicz, Yasser M. Shaker, Anna Swiderska-Sroda, and Witold Lojkowski.
2021. "Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses" Pharmaceutics 13, no. 12: 2174.
https://doi.org/10.3390/pharmaceutics13122174
APA Style
AbouAitah, K., Allayh, A. K., Wojnarowicz, J., Shaker, Y. M., Swiderska-Sroda, A., & Lojkowski, W.
(2021). Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses. Pharmaceutics, 13(12), 2174.
https://doi.org/10.3390/pharmaceutics13122174